Researchers are developing and testing various influenza vaccine approaches that aim to provide broad protection against different influenza A viruses. These approaches include mosaic virus-like particles, nanoparticle vaccines, and multivalent vaccines, which have shown promise in eliciting humoral and cellular immune responses. The development of these vaccines is part of a broader effort to create a universal influenza vaccine that can offer protection against multiple strains of the virus.